Daxor Return on Tangible Equity 2010-2011 | DXR

Current and historical return on tangible equity values for Daxor (DXR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Daxor Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2011-12-31 $-0.01B $0.04B -14.46%
2011-09-30 $0.00B $0.04B -6.78%
2011-06-30 $0.00B $0.05B 8.56%
2011-03-31 $0.00B $0.05B 8.70%
2010-12-31 $0.01B $0.05B 10.81%
2010-09-30 $0.00B $0.05B 4.30%
2010-06-30 $0.00B $0.04B 4.26%
2010-03-31 $0.01B $0.05B 16.84%
2009-12-31 $0.01B $0.05B 13.71%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.042B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.118B 19.83
Encompass Health (EHC) United States $12.188B 25.84
DaVita (DVA) United States $10.277B 14.45
Chemed (CHE) United States $8.063B 25.34
Elanco Animal Health (ELAN) United States $6.859B 14.69
Option Care Health (OPCH) United States $5.174B 23.07
RadNet (RDNT) United States $4.157B 263.86
Amedisys (AMED) United States $3.189B 21.45
Addus HomeCare (ADUS) United States $2.075B 22.79
LifeStance Health (LFST) United States $2.045B 0.00
Astrana Health (ASTH) United States $1.444B 35.76
U.S Physical Therapy (USPH) United States $1.170B 30.20
Aveanna Healthcare Holdings (AVAH) United States $0.958B 54.56
Pennant (PNTG) United States $0.954B 35.03
Atai Life Sciences (ATAI) Germany $0.423B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.044B 0.00
Ontrak (OTRK) United States $0.006B 0.00
Psychemedics (PMD) United States $0.000B 0.00